NFRA plans 7 papers to strengthen the audit standards

In an effort to improve audit quality, the National Financial Reporting Authority (NFRA) is set to release a series of papers addressing critical areas of statutory audits. NFRA Chairman Ajay Bhushan Pandey told FE that seven such papers are planned for release over the next 2–3 months.

“Based on our experience and the current gaps observed in overall auditing, we have identified critical areas requiring attention from auditors, audit committee members, independent directors, and other board directors. These papers are aligned with international practices followed by regulatory agencies like the PCAOB,” Pandey said.

“Keeping in view NFRA’s objectives of protecting public interest and investor protection, NFRA is commencing with this series of auditor-audit committee interactions, which will be issued on significant areas of accounting and auditing, from time to time,” the paper said.

Also Read South Western Railway announces partial cancellation, diversion of trains for track maintenance Poco F7, F7 Pro quick review: Limitless value?

The first paper in the series, titled Auditor-Audit Committee Interactions Series 1, highlights key areas where audit committees or board directors should engage with auditors, particularly regarding accounting estimates and judgments.

“Within that, this communication includes aspects pertaining to audit of expected credit losses (ECL) for financial assets and other items as required by Ind AS 109, financial instruments,” the paper said. The paper further said that auditors and audit committees work towards the common goals of ensuring audit quality and integrity of financial statements.

“Section 177 of Companies Act 2013 requires the audit committee to review the financial statements and auditors report thereon; review and monitor the effectiveness of the audit process; valuation of undertakings or assets of the company; and evaluation of internal financial controls and risk management system,” it said.

 » Read More

Related Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

How will markets open today? Here are top 7 cues to watch ahead of trading on February 11

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 are implied to open on a higher note on Tuesday. Also, Asian markets opened majorly on a higher note in early trade hours as investors looked past the tariff threats from Donald Trump. Previously, on Monday, the NSE Nifty 50 finished the

Stocks To Watch: Reliance Ind, Grasim Ind, Bata, Titan, ONGC, IHCL, Nykaa, Lupin, Eicher Motors, Ahoka Buildcon

GIFT Nifty indicated that Indian equity indices BSE Sensex and NSE Nifty 50 may see a higher opening on Tuesday. Here’s a look at the key stocks to watch in trade. Stocks in Focus: Here’s a comprehensive list of stocks to keep in mind before you start your day. From Reliance Industries to Ashoka Buildcon

DIIs place big bets on 2 pharma giants. Multibaggers in the making?

By Suhel Khan As the world’s largest supplier of generic drugs, renowned for its cost-effective vaccines and generic medicines, India plays a very important role in global medicine. The Indian pharmaceutical industry has transformed into a flourishing sector, currently ranking third globally in terms of production volume and 14th in terms of value. Over the

Rupee fall hurts India Inc hard

The rupee inched closer to the 88-mark against the US dollar on Monday, putting companies in import-sensitive sectors on the edge. While firms fear a surge in imported inflation on account of rupee depreciation, consumer electronics companies, for instance, are taking price hikes to protect margins. In sectors such as thermal power, where the cost

Bata India Q3 profit grows marginally to Rs 58.6 crore on weak demand

Footwear major Bata India on Monday reported a marginal 1% growth in its net profit at Rs 58.6 crore during the October-December quarter, as compared to Rs 57.9 crore in the same quarter in 2023-24. Bloomberg consensus estimates had pegged the net profit during the quarter at Rs 72 crore.  The company’s revenue from operations